GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Hoth Therapeutics Inc.
Hoth Therapeutics is a biotech company with a diversified portfolio of drug candidates. Its stock price reflects the risks and opportunities associated with each of its clinical projects. The chart is a history of successes and failures in drug development.
Share prices of companies in the market segment - Pharma skin
Hoth Therapeutics is a biopharmaceutical company developing treatments for dermatological conditions such as eczema and acne, as well as other conditions. We've categorized it as a "Pharma: Skin" stock, and the chart below shows how investors value companies in the dermatology sector.
Broad Market Index - GURU.Markets
Hoth Therapeutics is a biopharmaceutical company with a diversified portfolio of developments aimed at treating skin diseases, allergies, and other conditions. It is a component of the GURU.Markets index, and the chart below shows how its stock compares to the broader market.
Change in the price of a company, segment, and market as a whole per day
HOTH - Daily change in the company's share price Hoth Therapeutics Inc.
For Hoth Therapeutics, Inc., a biopharmaceutical company, daily price change is a measure of the high volatility typical of the sector. This metric reflects the market's reaction to drug development news and serves as a risk assessment parameter.
Daily change in the price of a set of shares in a market segment - Pharma skin
Hoth Therapeutics, Inc. is a biotech company. This chart highlights the extreme volatility of the sector. Comparison with HOTH's performance, which focuses on dermatology, helps to assess it as a high-risk, clinical-data-driven asset.
Daily change in the price of a broad market stock, index - GURU.Markets
Hoth Therapeutics is a pharmaceutical company focused on dermatology. Its shares are driven by successful drug commercialization and clinical trial results. The dynamics of this niche healthcare segment are part of a larger and more diverse picture of the overall stock market.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Hoth Therapeutics Inc.
Hoth Therapeutics, Inc.'s year-over-year performance tells the story of its diversified early-stage development pipeline. Its 12-month market cap is highly volatile and depends on developments across its various programs, from skin disease treatments to chemotherapy side effects management.
Annual dynamics of market capitalization of the market segment - Pharma skin
Hoth Therapeutics, Inc. is an early-stage biotech company with a diversified portfolio. Its stock performance is entirely dependent on the results of preclinical and clinical trials. The chart reflects the high risks and speculative nature typical of this sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Hoth Therapeutics is a clinical-stage biotech whose fate depends on scientific breakthroughs, not the state of the economy. Its stock price reflects investor hopes for the success of new drug trials. The company's chart exists in a world of its own, where the main events are data releases.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Hoth Therapeutics Inc.
Hoth Therapeutics is a clinical-stage biopharmaceutical company. Its monthly performance directly reflects news from its diverse clinical pipeline. Any data on its programs, from dermatology to oncology, triggers investor reactions.
Monthly dynamics of market capitalization of the market segment - Pharma skin
This chart reflects the dynamics of the volatile biotech sector. For Hoth, a clinical-stage company with a diversified portfolio, it's the backdrop. Its movements illustrate how successes and failures in any of its many programs affect investor sentiment.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Hoth Therapeutics is a biopharmaceutical company with a diversified early-stage pipeline. Assessing its prospects requires analyzing each of its projects. While the overall market chart provides only background information, Hoth's performance is driven by development news, which can trigger sharp moves counter to any market trend.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Hoth Therapeutics Inc.
Hoth Therapeutics, a biopharmaceutical company with a broad and diversified pipeline, exhibits high volatility. Weekly stock performance reflects news about progress in any of its numerous clinical areas, from dermatology to COVID-19 treatment.
Weekly dynamics of market capitalization of the market segment - Pharma skin
Hoth Therapeutics operates in the volatile biopharmaceutical sector, where investor sentiment often influences all players. M&A news or general regulatory changes can lift or derail the entire sector. The chart will show whether HOTH is moving with the industry or whether its diversified portfolio is creating its own story.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Hoth Therapeutics, as a biotech company, often ignores broader market trends. Its fate depends not on GDP or inflation, but on the results of clinical trials. The chart below clearly demonstrates how HOTH shares can rise or fall on their own news, while the overall market moves in a different direction.
Market capitalization of the company, segment and market as a whole
HOTH - Market capitalization of the company Hoth Therapeutics Inc.
The Hoth Therapeutics chart is a diversified bet on early-stage biotech. The company's market cap, with a portfolio of developments in various fields, reflects investors' hopes that at least one of its projects will succeed. Its volatility reflects the market's assessment of this high-risk approach.
HOTH - Share of the company's market capitalization Hoth Therapeutics Inc. within the market segment - Pharma skin
Hoth Therapeutics is a biopharmaceutical company with a diversified pipeline, ranging from skin treatments to COVID-19 therapies. Its sector share reflects this broad strategy. The chart shows how the market values its various research programs and their chances of success.
Market capitalization of the market segment - Pharma skin
Hoth Therapeutics is a biopharmaceutical company developing drugs to treat skin diseases and other conditions. The chart below shows the market capitalization of the dermatology pharmaceutical sector. This represents a market seeking new solutions to improve patients' quality of life.
Market capitalization of all companies included in a broad market index - GURU.Markets
Hoth Therapeutics is a biopharmaceutical company with a diversified pipeline, ranging from dermatology drugs to COVID-19 treatments. Its market capitalization reflects this broad strategy. The chart below shows the economic weight of companies with multiple projects.
Book value capitalization of the company, segment and market as a whole
HOTH - Book value capitalization of the company Hoth Therapeutics Inc.
Hoth Therapeutics' foundation is a diversified portfolio of developments. The company's book value consists of licenses for several drug candidates for treating various diseases, from skin diseases to respiratory diseases, and cash flow for advancing them through R&D. The chart below shows how the company manages its risky but promising research capital.
HOTH - Share of the company's book capitalization Hoth Therapeutics Inc. within the market segment - Pharma skin
Hoth Therapeutics, a biopharmaceutical company, has key assets in the form of R&D laboratories for developing skin treatments. The S_BCap_Seg graph shows its share of scientific infrastructure, reflecting its focus on research.
Market segment balance sheet capitalization - Pharma skin
Hoth Therapeutics is a clinical-stage biopharmaceutical company. Its value lies in the potential of its drugs. A book value chart shows that its assets are almost entirely intangible, which is typical for an innovative company far from mass production.
Book value of all companies included in the broad market index - GURU.Markets
Hoth Therapeutics' book value represents a diversified portfolio of biotech developments. The company's assets are not a single laboratory, but rather the rights to several promising early-stage molecules for the treatment of skin diseases, asthma, and other conditions. This capital is spread across several areas to mitigate risk.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Hoth Therapeutics Inc.
Hoth Therapeutics is a clinical-stage biopharmaceutical company with a diversified portfolio. Its book value is cash. Its market capitalization is the sum of investor expectations for the success of its various drug candidates in areas such as dermatology and immunology.
Market to book capitalization ratio in a market segment - Pharma skin
Hoth Therapeutics is a biopharmaceutical company with a diversified pipeline. Its value is the sum of expectations for several projects. The chart shows how the market values this pipeline and its pipeline potential compared to its book value, which is primarily comprised of cash.
Market to book capitalization ratio for the market as a whole
Hoth Therapeutics is a biopharmaceutical company with a diversified development portfolio in various fields, including dermatology. Its value is the sum of the potential of its various projects. The chart shows how the market values this risk diversification strategy in biotech, where the success of a single drug can offset all costs.
Debts of the company, segment and market as a whole
HOTH - Company debts Hoth Therapeutics Inc.
Hoth Therapeutics, a biopharmaceutical company with a diversified portfolio, uses debt to finance its numerous developments. This chart shows how the company raises funds to advance its candidates in dermatology, oncology, and other fields through the preclinical and early clinical stages.
Market segment debts - Pharma skin
Hoth Therapeutics is a clinical-stage biopharmaceutical company with a diversified pipeline across various therapeutic areas. Funding multiple projects simultaneously requires significant capital and efficient resource management. This chart shows its financial position and ability to support its research programs.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Hoth Therapeutics Inc.
Hoth Therapeutics is a biopharmaceutical company focused on developing treatments for skin diseases. This chart shows whether the company is raising debt financing for its research. For a company in the clinical trials stage, reliance on debt is critical, as failure in research could lead to inability to service the debt.
Market segment debt to market segment book capitalization - Pharma skin
Hoth Therapeutics is a biopharmaceutical company focused on dermatology. This chart for the biotech sector shows how the industry as a whole raises capital to fund clinical trials. It helps understand how the company's financial position is typical for an industry where the path to market is long and expensive.
Debt to book value of all companies in the market
Hoth Therapeutics is a biopharmaceutical company focused on developing treatments for skin diseases. This chart, showing the debt-to-book value ratio, is important for assessing the investment climate in biotech. The market's willingness to finance companies with long development cycles determines Hoth's ability to attract capital for research.
P/E of the company, segment and market as a whole
P/E - Hoth Therapeutics Inc.
Hoth Therapeutics is a biotech company with a diversified pipeline of developments in areas such as dermatology and COVID-19 treatment. This chart reflects investor assessments of its broad, yet early, pipeline. Its dynamics show how the market weighs the chances of success in each area, where a breakthrough in any one could lead to significant growth.
P/E of the market segment - Pharma skin
Hoth Therapeutics is a biotech company. This chart shows the average P/E for the biotech sector. Comparing the company's P/E to this benchmark allows us to understand how the market values its diversified but early-stage development portfolio compared to the average biotech company, which may be more focused.
P/E of the market as a whole
Hoth Therapeutics is a biopharmaceutical company with a diversified pipeline of developments in various fields, from dermatology to COVID-19 treatment. This chart shows the sentiment in the biotech sector. It helps understand how the market views this "multiple-shot" strategy—as a way to diversify risk or as a dissipation of resources that prevents focus on a single promising area.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Hoth Therapeutics Inc.
Hoth Therapeutics is a clinical-stage biopharmaceutical company with a diversified portfolio of drugs targeting dermatology and other areas. The chart reflects speculative revenue expectations, which depend on the success of clinical trials in multiple areas simultaneously.
%20P%2FE%20Hoth%20Therapeutics%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Hoth-Therapeutics-Inc.&v=1772652427596 "Chart of the company's future (projected) P/E Hoth Therapeutics Inc.")
Future (projected) P/E of the market segment - Pharma skin
Hoth Therapeutics is a biopharmaceutical company with a diversified pipeline targeting skin diseases, allergies, and other conditions. This chart shows how its future revenue expectations compare to the industry average, reflecting its strategy of developing multiple drugs simultaneously.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-skin&v=1772652427646 "Future (projected) P/E graph of the market segment - Pharma skin")
Future (projected) P/E of the market as a whole
Hoth Therapeutics is a clinical-stage biotechnology company with a diversified pipeline of developments in dermatology, oncology, and other fields. Its value is the sum of expectations across several research projects. It is not tied to general market forecasts, but is determined by research data.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772652427680 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Hoth Therapeutics Inc.
Hoth Therapeutics is a clinical-stage biopharmaceutical company developing drugs for the treatment of dermatological diseases and other conditions. Its financial metrics currently reflect research and development expenses. This chart illustrates the company's investment in developing its new therapeutic portfolio.
Profit of companies in the market segment - Pharma skin
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for skin conditions such as acne and eczema. This chart shows the profitability of the dermatology segment. The company's ongoing R&D expenditures impact overall profitability, but its potential success could offer new treatment options for millions of patients and drive growth for the niche.
Overall market profit
Hoth Therapeutics is a clinical-stage biopharmaceutical company developing drugs for the treatment of dermatological diseases. Its value and prospects are determined solely by its research results and the potential of its developments. This chart shows general market trends, while Hoth Therapeutics is pursuing its own scientific path.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Hoth Therapeutics Inc.
Hoth Therapeutics is a clinical-stage biopharmaceutical company focused on developing treatments for skin diseases and other conditions. The future revenue forecast reflected here is long-term and speculative, dependent entirely on the success of clinical trials. It demonstrates the analysts' confidence in the scientific potential of the company's development pipeline.
%20profit%20of%20the%20company%20Hoth%20Therapeutics%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Hoth-Therapeutics-Inc.&v=1772652427772 "Graph of future (projected) profit of the company Hoth Therapeutics Inc.")
Future (predicted) profit of companies in the market segment - Pharma skin
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing drugs for the treatment of skin and other diseases. This chart shows revenue projections for the dermatology pharmaceutical segment. It reflects expectations for innovative treatments targeting a high-demand market.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-skin&v=1772652427781 "Graph of future (predicted) profits of companies in a market segment - Pharma skin")
Future (predicted) profit of the market as a whole
Hoth Therapeutics is a biopharmaceutical company focused on dermatology. As with any development-stage biotech, access to capital is critical for Hoth. The market's overall profit outlook influences investors' willingness to finance risky projects. The chart below demonstrates the current favorable investment climate.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772652427840 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Hoth Therapeutics Inc.
Hoth Therapeutics is a biopharmaceutical company developing drugs to treat skin diseases and other conditions. Being in the clinical stage, it may not have stable revenue. P/S will become important after the product launch to assess how the market will perceive its developments.
P/S market segment - Pharma skin
Hoth Therapeutics is a clinical-stage biopharmaceutical company with a diversified portfolio targeting various areas, including dermatology and skin disease treatment. This chart shows how the market views their multidisciplinary approach and the combined potential of their pipeline, expressed as a valuation relative to minimum current revenue.
P/S of the market as a whole
Hoth Therapeutics is a biotech company with a diversified pipeline across various therapeutic areas, including dermatology. The company has no commercial revenue. This chart, based on actual revenue, highlights that Hoth's valuation is a bet on the success of at least one of its many research projects.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Hoth Therapeutics Inc.
Hoth Therapeutics is a biopharmaceutical company with a diversified pipeline across various therapeutic areas. This chart reflects investors' aggregated expectations for future revenue from any of its project candidates that have the potential to succeed and reach commercialization, diversifying risk across multiple fronts.
%20P%2FS%20Hoth%20Therapeutics%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Hoth-Therapeutics-Inc.&v=1772652427997 "The graph of the company's future (projected) P/S Hoth Therapeutics Inc.")
Future (projected) P/S of the market segment - Pharma skin
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for skin conditions such as acne and other disorders. This chart shows how the market assesses the future commercial potential of its pipeline. It compares it to other companies in the dermatology sector, reflecting its niche specialization.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20skin&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-skin&v=1772652428085 "Future (projected) P/S market segment graph - Pharma skin")
Future (projected) P/S of the market as a whole
Hoth Therapeutics is a biopharmaceutical company with a diversified pipeline of developments in dermatology, cancer treatment, and other diseases. This chart shows overall revenue projections, and HOTH exemplifies how early-stage companies with a wide range of potential products attract investors betting on the success of at least one of their areas.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772652428151 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Hoth Therapeutics Inc.
Hoth Therapeutics is a clinical-stage biopharmaceutical company developing drugs for the treatment of dermatological and other conditions. Because its products are still in development and have not received approval, sales revenue is not included in this chart. Revenue may only be generated through partnerships.
Sales of companies in the market segment - Pharma skin
Hoth Therapeutics is a biopharmaceutical company with a diversified development portfolio. At this stage, its revenue, if any, may come from licensing agreements for one of its projects. This chart allows investors to assess which therapeutic areas have already begun generating revenue.
Overall market sales
Hoth Therapeutics is a clinical-stage biopharmaceutical company focused on various therapeutic areas. Its value is determined by progress in drug development. This overall market performance chart is unrelated to scientific and clinical developments, which are Hoth's sole drivers.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Hoth Therapeutics Inc.
Hoth Therapeutics is a clinical-stage biopharmaceutical company with a diversified pipeline of developments in dermatology, oncology, and other fields. Its revenue forecast is entirely dependent on research success. This chart shows analysts' speculative expectations for the commercial potential of its various programs.
%20sales%20of%20the%20company%20Hoth%20Therapeutics%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Hoth-Therapeutics-Inc.&v=1772652428296 "Schedule of future (projected) sales of the company Hoth Therapeutics Inc.")
Future (projected) sales of companies in the market segment - Pharma skin
Hoth Therapeutics is a clinical-stage biopharmaceutical company focused on developing treatments for skin diseases. This chart shows projected revenue for the dermatology segment. It helps estimate potential demand for new treatments, which is key to commercializing Hoth's pipeline.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-skin&v=1772652428356 "Schedule of future (projected) sales of companies in the market segment - Pharma skin")
Future (projected) sales of the market as a whole
Hoth Therapeutics is a clinical-stage biopharmaceutical company developing drugs for the treatment of dermatological and other diseases. Its value is determined by the potential of its scientific developments. This chart of overall market expectations reflects investor risk appetite, which is critical for funding long-term and capital-intensive biotech projects.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772652428395 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Hoth Therapeutics Inc.
Hoth Therapeutics is a clinical-stage biopharmaceutical company with a diversified pipeline. This chart reflects its current status as a research-focused company. It demonstrates the company's investment in research, and its future ability to generate revenue depends on the success of its developments in various areas.
Market segment marginality - Pharma skin
Hoth Therapeutics is a biopharmaceutical company developing treatments for skin conditions such as eczema and acne, as well as other therapeutic areas. This chart shows the average profitability in the dermatology sector. It provides an idea of the potential profitability of Hoth's innovative products if they are successfully launched.
Market marginality as a whole
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for skin diseases. Its value is based on expected research results. This gross margin chart is not relevant to Hoth's valuation, which depends solely on scientific data and the potential market size for its future products.
Employees in the company, segment and market as a whole
Number of employees in the company Hoth Therapeutics Inc.
Hoth Therapeutics is a clinical-stage biopharmaceutical company with a diversified development pipeline. Its small team manages multiple projects simultaneously, often in partnership with other organizations. This graph illustrates how a compact team can effectively manage multiple R&D programs.
Share of the company's employees Hoth Therapeutics Inc. within the market segment - Pharma skin
Hoth Therapeutics is a clinical-stage biopharmaceutical company developing treatments targeting skin conditions such as eczema. This chart highlights its scientific focus. It illustrates the proportion of dermatologists and researchers working on developing innovative treatments to improve the quality of life for patients with skin conditions that Hoth brings together.
Number of employees in the market segment - Pharma skin
Hoth Therapeutics, Inc. is a biopharmaceutical company developing drugs for the treatment of dermatological diseases. This chart illustrates employment in the skin pharmaceuticals sector. The growing number of specialists in this field indicates a high demand for new effective and safe treatments for skin conditions, from acne to eczema.
Number of employees in the market as a whole
Hoth Therapeutics, Inc. is a biopharmaceutical company focused on developing treatments for skin diseases. Dermatology is a large and stable segment of the pharmaceutical market. This graph reflects overall employment, and innovation in this field supports job creation for scientists and medical professionals.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Hoth Therapeutics Inc. (HOTH)
Hoth Therapeutics is an early-stage biopharmaceutical company. Its value is a pure option for future success. This chart illustrates the enormous value the market places on each scientist and their research. It's a valuation of intellectual capital in its most concentrated form—at the scientific hypothesis stage.
%20of%20the%20company%20Hoth%20Therapeutics%20Inc.%20(HOTH)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Hoth-Therapeutics-Inc.-HOTH&v=1772652428812 "Chart of market capitalization per employee (in thousands of dollars) of the company Hoth Therapeutics Inc. (HOTH)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma skin
Hoth Therapeutics is a biotech company focused on dermatology. Its value depends on the success of its R&D. Market capitalization per employee reflects investor expectations for its pipeline. If the market capitalization is above the sector average, the market sees significant potential in its skin treatments.
%20by%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-skin&v=1772652428869 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma skin")
Market capitalization per employee (in thousands of dollars) for the overall market
Hoth Therapeutics is a clinical-stage biopharmaceutical company developing drugs to treat skin diseases and other conditions. Its value reflects the potential of its pipeline. This chart shows how the market values the scientific potential of a small team working on new therapeutic solutions.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772652428989 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Hoth Therapeutics Inc. (HOTH)
Hoth Therapeutics is a biotech company with a diversified portfolio of R&D projects (from dermatology to oncology). It's a pure R&D business with no commercial products. This graph is in negative territory and shows how much investor capital is "burned" for each scientist working on one of these numerous projects.
%20Chart%20Hoth%20Therapeutics%20Inc.%20(HOTH)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Hoth-Therapeutics-Inc.-HOTH&v=1772652429053 "Company Profit Per Employee (in thousands of dollars) Chart Hoth Therapeutics Inc. (HOTH)")
Profit per employee (in thousands of dollars) in the market segment - Pharma skin
Hoth Therapeutics is a biopharmaceutical company developing drugs for dermatological diseases. This chart reflects the potential of their developments. For a company in clinical development, it illustrates the value a small team of scientists can create if their drugs are successful, a key factor for investors in the biotech sector.
%20in%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-skin&v=1772652429073 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma skin")
Profit per employee (in thousands of dollars) for the market as a whole
Hoth Therapeutics is a clinical-stage biopharmaceutical company developing treatments for skin diseases, allergies, and other conditions. Like most biotech companies without stable revenue, this chart reflects R&D intensity. It shows how much money is invested in research per employee to advance drugs through the pipeline.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772652429100 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Hoth Therapeutics Inc. (HOTH)
Hoth Therapeutics is a clinical-stage biopharmaceutical company. This graph, showing minimal or no revenue per employee, is the industry norm. It reflects the period of investment in research and development. Successful commercialization of the developed drugs will lead to exponential growth of this metric.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Hoth-Therapeutics-Inc.-HOTH&v=1772652429207 "Sales chart per company employee Hoth Therapeutics Inc. (HOTH)")
Sales per employee in the market segment - Pharma skin
Hoth Therapeutics (HOTH) is a clinical-stage biopharmaceutical company developing treatments for dermatological conditions (e.g., acne, psoriasis) and other disorders. This chart shows the average revenue per employee in the pharmaceutical segment. For Hoth, which is in the R&D stage, comparing it to this benchmark (zero) highlights their focus on science rather than current sales.
Sales per employee for the market as a whole
Hoth Therapeutics (HOTH) is a clinical-stage biotech with a diversified portfolio (dermatology, Alzheimer's). Like other R&D companies (LIXT, PMN), revenue is virtually nonexistent. This metric is meaningless. The company's entire value lies in its research and development and patents.
Short shares by company, segment and market as a whole
Shares shorted by company Hoth Therapeutics Inc. (HOTH)
Hoth Therapeutics is a microcap biotech with a highly diversified and early pipeline (from acne to Alzheimer's). This chart shows that investors see this as a lack of focus. Bears are betting that the company is simply wasting its meager resources, with no chance of bringing any of its numerous speculative projects to market.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Hoth-Therapeutics-Inc.-HOTH&v=1772652429325 "Short Shares Chart for the Company Hoth Therapeutics Inc. (HOTH)")
Shares shorted by market segment - Pharma skin
Hoth Therapeutics (HOTH) is a biotech with a very diverse portfolio: the company is trying to treat everything from acne to lung diseases. This chart highlights the pessimism in the sector. The growing short positioning across the industry is a bet against these "biotech orchestras." Investors doubt HOTH has the focus and, more importantly, the capital to complete even one of its numerous and risky projects.
Shares shorted by the overall market
Hoth Therapeutics is a clinical-stage biotech with a highly diversified portfolio, ranging from acne to Alzheimer's disease. This chart measures overall fear. When investors are afraid, they see HOTH as a capital drain. They don't believe a small company has the capital for so many different projects, and they sell off shares, fearing failure on all fronts.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Hoth Therapeutics Inc. (HOTH)
Hoth Therapeutics (HOTH) is a clinical-stage biotech developing drugs for dermatological and other conditions. The stock is volatile on news. This oscillator measures the rate of price change. It helps identify when investor enthusiasm (above 70) or disappointment (below 30) about the trial peaks.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Hoth-Therapeutics-Inc.-HOTH&v=1772652429378 "RSI 14 indicator chart for the company's stock Hoth Therapeutics Inc. (HOTH)")
RSI 14 Market Segment - Pharma skin
Hoth Therapeutics (HOTH) is a biotech company with a diversified portfolio, working on dermatology (eczema) and other treatments. This chart tracks overall sentiment in the Pharma/Dermatology sector. It helps investors understand whether HOTH's performance reflects its trials or whether the entire biotech sector is overheated or oversold.
RSI 14 for the overall market
Hoth Therapeutics (HOTH) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic risks running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast HOTH (Hoth Therapeutics Inc.)
Hoth Therapeutics is a biopharmaceutical company with a diversified R&D portfolio, including drugs for dermatological diseases, acne, and psoriasis. This chart shows the speculative average 12-month price target from analysts, based on their assessment of this risky portfolio.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-HOTH-Hoth-Therapeutics-Inc.&v=1772652429470 "A chart showing analyst consensus forecasts for the expected stock price. HOTH (Hoth Therapeutics Inc.)")
The difference between the consensus estimate and the actual stock price HOTH (Hoth Therapeutics Inc.)
Hoth Therapeutics is a biotech company with a diversified R&D portfolio, including drugs ranging from dermatitis to Alzheimer's. This chart measures the gap between the current share price and the consensus target price. It shows the potential analysts see in their early and risky clinical programs.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-HOTH-Hoth-Therapeutics-Inc.&v=1772652429503 "A chart showing the difference between the consensus forecast and the actual stock price. HOTH (Hoth Therapeutics Inc.)")
Analyst consensus forecast for stock prices by market segment - Pharma skin
Hoth Therapeutics is a biotech company with a diversified R&D pipeline focused on dermatology (eczema) and cancer side effects. This chart shows analysts' overall expectations for the skin pharma sector. It reflects the confidence experts have in the company's R&D programs in these competitive areas.
Analysts' consensus forecast for the overall market share price
Hoth Therapeutics is a biotech company developing drugs to treat dermatological diseases and allergies. This chart shows the overall market "risk appetite." For Hoth, a high-risk clinical-stage company, overall market optimism is critical to attracting the capital needed to fund lengthy and expensive clinical trials.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Hoth Therapeutics Inc.
Hoth Therapeutics is a biotech incubator. They don't have a single bet; their model is to identify and license promising R&D projects (from universities) in various fields (dermatology, AI, Alzheimer's). This chart is a summary indicator of their R&D portfolio strategy. It reflects their ability to select winners and their reliance on news flow.
AKIMA Market Segment Index - Pharma skin
Hoth Therapeutics (HOTH) is a biopharmaceutical company with a diversified portfolio. They develop drugs for the treatment of dermatological diseases (eczema), and also focus on biodefense and Alzheimer's treatment. The chart shows the average index for the segment, helping investors assess how this broad but risky portfolio compares to the average.
The AKIM Index for the overall market
Hoth Therapeutics is a biopharmaceutical company developing new treatments for dermatological and chronic diseases. This chart, which reflects the market average, provides a macro backdrop. It helps assess how this early-stage speculative story compares to overall economic trends and risk appetite.
